Skip to main content
Equibles

Andrew Phillips

Chairman

OnKure Therapeutics, Inc. (OKUR)

Board Member

OnKure Therapeutics, Inc. (OKUR)

Equibles does not estimate personal net worth.

Get an email with a short summary when OnKure Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get OKUR alerts

About Andrew Phillips

Andrew Phillips is recorded as Chairman at OnKure Therapeutics, Inc. (OKUR) since October 4, 2024 and Board Member at OnKure Therapeutics, Inc. (OKUR) since January 1, 2024. The newest filing on record that lists Andrew Phillips as Board Member at OnKure Therapeutics, Inc. (OKUR) is dated April 21, 2026. Earlier roles on record: Board Member at Enliven Therapeutics, Inc. (ELVN) until January 7, 2026. OnKure Therapeutics, Inc. reported in an 8-K filed October 8, 2024 that Andrew Phillips was appointed Chair of the Board, effective October 4, 2024. OnKure Therapeutics, Inc. reported in an 8-K filed October 8, 2024 that Andrew Phillips was appointed Class III director. OnKure Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at OnKure Therapeutics, Inc. includes Nicholas A. Saccomano (CEO and Board Member), Nicholas A. Saccomano, Ph.D. (CEO), Nicholas Saccomano (CEO and Board Member) and 7 others.

“Also on October 4, 2024, Andrew Phillips, Ph.D. was appointed as the Chair of the Board.”
OnKure Therapeutics, Inc. Form 8-K, filed October 8, 2024 · Read the filing
“Effective as of the Effective Time, Nicholas Saccomano and Isaac Manke were appointed as Class I directors, R. Michael Carruthers, Valerie M. Jansen and Edward T. Mathers were appointed as Class II directors and Andrew Phillips and Michael Grey were appointed as Class III directors.”
OnKure Therapeutics, Inc. Form 8-K, filed October 8, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at OnKure Therapeutics, Inc.

Recent activity